In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medeus: How To Find & Buy a Ready-Made Euro Infrastructure

Executive Summary

Apax Partners paid $120 million for Elan's European sales and marketing infrastructure--renamed Medeus--to buy into the in-licensing game with a ready-made continent-wide commercial network. Few specialty companies can match its scope. But with little or no track record and a portfolio of mostly older, sometimes off-patent drugs, Medeus may nevertheless have to work hard to convince licensors to hand over their products.
Advertisement

Related Content

Europe's New Spec Pharma Models
Intendis: Mid-Sized Specialist Spawns Small Specialist
Ex-Shire Team Builds New Euro-Specialty Group
The Anti-Global, Specialist Strategy: Why Bayer's Choice Might Be Right for Other Pharmas
Europe's Flavors of Sustainable BioPharma
Strakan/Proskelia: Creating Long-Term Value
The Pan European Licensing Opportunity
Strakan: Refining Search & Development
Pharmion Bets That Europe is Alright for Some
Elan Recovery Slowed By King

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV004850

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel